FREDERICK, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced the sale of a Custom Engineered System (CES) in the United Kingdom to an international pharmaceutical manufacturing organization. The system is being delivered as part of a bespoke, modular cleanroom platform designed, engineered, and validated by Total Clean Air Limited (“TCA”), one of the United Kingdom’s leading autho ...

Core Insights - TOMI Environmental Solutions, Inc. has announced the purchase of its SteraMist Hybrid System for a private research university on the East Coast, aimed at ensuring the safety and sterilization of reusable medical equipment for patient homes [1] - The facility requires a reliable decontamination solution for its sterilization room, which is crucial for meeting safety protocols for reusable medical products [2] - The integration of the SteraMist Hybrid System demonstrates its capability to meet the high standards set by healthcare organizations, marking the second sale in a $13 million pipeline for automated installation projects [3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, utilizing its Binary Ionization Technology® (BIT™) platform to provide indoor surface disinfection solutions [4] - The BIT™ solution, developed under a defense grant with DARPA, uses a low percentage of Hydrogen Peroxide to create a fog of ionized Hydrogen Peroxide (iHP™), which effectively kills germs [4] - TOMI's products cater to a wide range of commercial structures, including hospitals, schools, and military facilities, as well as residential applications [5] Industry Context - The demand for reliable decontamination solutions is critical in the healthcare sector, particularly for medical devices and products that are reprocessed for patient use [2] - The successful deployment of the SteraMist Hybrid System at a research university highlights the increasing need for advanced sterilization technologies in high-stakes medical environments [3]

Core Insights - TOMI Environmental Solutions, Inc. has announced the adoption of its SteraMist ionized Hydrogen Peroxide (iHP) technology by a leading Cell and Gene Therapy (CGT) manufacturer for a commercial-scale facility, enhancing contamination control strategies to meet cGMP requirements [1][3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, specializing in indoor surface disinfection through its Binary Ionization Technology® (BIT™) platform, which utilizes low percentage Hydrogen Peroxide to create a germ-killing aerosol [5][6] - The company provides solutions for a wide range of commercial structures, including hospitals, medical facilities, and various other environments [6] Industry Context - The rapid growth of the Cell and Gene Therapy sector is driving demand for advanced sterilization solutions, positioning TOMI at the forefront of this market shift [4] - As CGT manufacturers transition from development to commercial production, there is an increasing need for validated and scalable contamination control solutions, which TOMI aims to address with its comprehensive offerings [3][4]

Core Insights - TOMI Environmental Solutions, Inc. has secured a significant purchase contract valued at approximately $500,000 from a leading biopharmaceutical company for the integration of its SteraMist Integrated Systems (SIS) platform into critical manufacturing infrastructure [1][2]. Group 1: Contract Details - The purchase order mandates the use of SteraMist iHP technology in passthrough fill boxes, essential for the client's sterile manufacturing and advanced therapeutic production processes [2]. - The SIS platform will provide a fully automated, rapid, and residue-free decontamination solution for critical chambers, with comprehensive installation and performance qualification services included [3]. Group 2: Market Demand and Future Prospects - The SIS platform, launched in late 2024, addresses the growing demand for automated, in-line, and high-throughput decontamination solutions, with a robust pipeline of orders anticipated throughout 2026 and beyond [4]. - The current order is part of a $13 million pipeline for automated installation projects, highlighting the effectiveness of the SIS platform in driving future business [4]. Group 3: Company Overview - TOMI Environmental Solutions, Inc. specializes in decontamination and infection prevention, utilizing its Binary Ionization Technology® (BIT™) platform, which produces a germ-killing aerosol using ionized Hydrogen Peroxide [6]. - The company serves a wide range of commercial structures, including hospitals, medical facilities, and various other environments, demonstrating the versatility of its products [7].

Core Viewpoint - TOMI Environmental Solutions, Inc. advocates for cruise lines to adopt hospital-grade disinfection technologies like SteraMist to enhance maritime decontamination standards and protect passengers and crew from health outbreaks [1][2][3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, utilizing its proprietary Binary Ionization Technology® (BIT™) platform to provide effective indoor surface disinfection solutions [4][5] - The BIT™ solution, developed under a defense grant with DARPA, employs a low percentage of Hydrogen Peroxide to create a fog of ionized Hydrogen Peroxide (iHP™), which acts as a germ-killing aerosol [4] Industry Context - The cruise industry is identified as a high-risk environment for health outbreaks due to close quarters and shared facilities, necessitating advanced disinfection methods to prevent the spread of pathogens like Norovirus and Legionella [2][3] - Recent incidents, such as a Norovirus outbreak affecting over 100 passengers on an AIDA Cruises vessel, highlight the urgent need for improved decontamination practices within the cruise sector [2] Product Application - SteraMist is positioned as a proactive solution for critical areas on cruise ships, including dining and entertainment spaces, crew health areas, and children's facilities, which are often neglected by traditional cleaning methods [2][3] - The technology allows for rapid and thorough disinfection, minimizing downtime and effectively containing potential outbreaks [2][3] Market Opportunity - The adoption of SteraMist is presented as a value proposition for cruise lines, promising increased passenger confidence, reduced operational risks from outbreaks, and a competitive marketing advantage [3] - The company encourages collaboration with the cruise industry and the public to promote the global adoption of enhanced disinfection technologies [3]

Summary of TOMI Environmental Solutions Conference Call Company Overview - **Company Name**: TOMI Environmental Solutions - **Ticker**: TOMZ - **Industry**: Disinfection and Decontamination - **Product**: SteraMist, an eco-friendly disinfection solution developed from DARPA technology Core Points and Arguments - **Product Efficacy**: SteraMist utilizes a low-percentage hydrogen peroxide (7.8%) converted through a cold plasma arc to create hydroxyl radicals that effectively neutralize pathogens, including spores and viruses, without leaving any residue [2][3][4] - **Market Opportunity**: The global market for disinfection is vast, spanning multiple industries including biotech, food and beverages, commercial services, and healthcare, with significant growth expected [4][16] - **Competitive Landscape**: Major competitors include STERIS and Bioquell, with TOMI positioned to outperform due to its unique technology and faster, more effective disinfection capabilities [5][10] - **Client Base**: Notable clients include Pfizer, Merck, NASA, and various government agencies, which validate the product's effectiveness and reliability [3][19] - **Regulatory Compliance**: The company adheres to stringent regulations, including FDA and EMA compliance, which enhances its credibility in the market [16][20] Financial Performance - **Revenue Growth**: Revenues increased by 38% over pre-COVID levels, with a 40% growth in the first half of 2025 compared to the same period in 2024 [21][14] - **Margins**: The company maintains gross margins of approximately 60%-62% [10][23] - **Recurring Revenue Model**: The business model is based on a "razor and blade" approach, where equipment sales drive recurring revenue from consumables [10][25] Market Segments - **Biotechnology and Life Sciences**: This segment is the largest revenue generator, including applications in pharmaceuticals and clean rooms [5][6] - **Food Safety**: Growing segment with increasing demand for sanitation solutions due to stricter regulations and food safety concerns [18][19] - **Healthcare**: Significant potential for growth, especially in hospitals, where SteraMist has demonstrated effectiveness in reducing infection rates [20][21] Future Outlook - **Market Expansion**: The company is focused on expanding its sales force and enhancing training programs to penetrate more healthcare facilities and other verticals [22][23] - **Technological Advancements**: Ongoing development of custom integration units and partnerships with laboratory equipment manufacturers to embed SteraMist technology [10][11] - **Regulatory Tailwinds**: Increased focus on biosecurity and infection control post-COVID is expected to drive demand for SteraMist solutions [16][24] Additional Insights - **Case Studies**: Successful case studies, such as the reduction of C. diff cases in hospitals, provide strong evidence of product effectiveness [20] - **Environmental Impact**: SteraMist's eco-friendly profile, with water and humidity as the only byproducts, positions it favorably against traditional disinfection methods [29][30] - **Global Health Concerns**: The company is prepared to address potential outbreaks and pandemics, leveraging its technology to provide effective solutions [24] This summary encapsulates the key points discussed during the TOMI Environmental Solutions conference call, highlighting the company's strengths, market opportunities, and future growth potential.

Core Insights - TOMI Environmental Solutions, Inc. will present at the Sidoti Year End Investor Conference on December 10-11, 2025, with CEO Dr. Halden Shane and CFO David Vanston available for one-on-one meetings [1][2] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology (BIT) platform, marketed under the SteraMist brand [3] - The BIT solution, developed with a defense grant from DARPA, utilizes a low percentage of hydrogen peroxide as its active ingredient and incorporates patented ionized Hydrogen Peroxide (iHP) technology for superior disinfection [3] - TOMI's products are applicable in various environments, including hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and emergency services [3]

Core Insights - TOMI Environmental Solutions, Inc. has made significant progress in its custom integration pipeline, valued at approximately $3 million, indicating strong momentum in the life sciences sector [1][6] - The company is strategically positioned as a turnkey solution provider in regulated industries, focusing on disinfection and decontamination solutions that are highly valued [2][7] Project Pipeline and Business Development - TOMI currently has ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, catering to both new and existing customers [1][5] - Several projects are expected to be completed by the end of the year, with additional initiatives in the procurement and planning stages, suggesting sustained business development into 2026 [5][10] Strategic Partnerships - The company's success is attributed to strategic partnerships with major enclosure manufacturers such as ESCO Micro Pte. Ltd., Steelco S.p.A., and others, which enhance TOMI's role as a bridge between advanced technology and practical application [3][4] - These partnerships facilitate the seamless integration of TOMI's iHP technology into existing systems, addressing market demand for comprehensive decontamination solutions [4][9] Market Positioning - TOMI focuses on serving the life science and medical device sectors, where contamination control is critical for product quality and patient safety [7][12] - The SIS and CES platforms offer customization capabilities to meet unique operational requirements, positioning TOMI as a strategic partner rather than just an equipment supplier [8][12] Long-term Growth Strategy - The company's emphasis on high-value partnerships in specialized sectors reflects a business model aimed at sustainable expansion rather than rapid volume growth [12] - By leveraging established manufacturer relationships, TOMI enhances its market presence and ensures customers receive integrated solutions with comprehensive support [9][12]

Core Viewpoint - TOMI Environmental Solutions, Inc. has filed a $50 million universal shelf registration statement with the SEC to enhance its financial flexibility for operational growth and strategic initiatives [1][2]. Financial Strategy - The registration statement will allow TOMI to offer and sell securities as needed, providing the company with the ability to efficiently access capital [2]. - TOMI has entered into a strategic advisory and placement arrangement with Bancroft Capital and established an equity line of credit (ELOC) facility with Hudson Global Ventures, allowing the sale of up to $20 million of common stock over a 24-month period [3]. Operational Performance - The CEO of TOMI highlighted strong sequential revenue growth and improved gross margins in Q3, indicating expanding customer adoption of the SteraMist® technology [4]. - The financing from the ELOC is intended to accelerate investments in innovation, manufacturing efficiency, and global distribution [4]. Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology® (BIT™) platform, which utilizes a low percentage of Hydrogen Peroxide to create a germ-killing aerosol [5]. - The company's products are designed for a wide range of commercial structures, including hospitals, cruise ships, schools, and military facilities [6].

Core Insights - TOMI Environmental Solutions, Inc. reported a quarterly loss of $0.02 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.01, marking a 100% earnings surprise [1] - The company generated revenues of $2.12 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 22.77% and down from $2.54 million year-over-year [2] - The stock has underperformed, losing approximately 22.9% since the beginning of the year, while the S&P 500 has gained 14.6% [3] Financial Performance - Over the last four quarters, TOMI Environmental Solutions has surpassed consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $3.63 million, and for the current fiscal year, it is -$0.10 on revenues of $8.98 million [7] Industry Outlook - The Waste Removal Services industry, to which TOMI belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact TOMI's stock performance [5] Future Expectations - The company's earnings outlook will be crucial for assessing future stock performance, particularly in light of management's commentary during the earnings call [4] - The estimate revisions trend for TOMI was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market [6]